T
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Price:
2 163
ILS
0.93%
Market Cap:
₪18.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tikun Olam Cannbit Pharmaceuticals Ltd
Capital Expenditures
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Tikun Olam Cannbit Pharmaceuticals Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
|
Capital Expenditures
₪71k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Capital Expenditures
-$501m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Capital Expenditures
-$47k
|
CAGR 3-Years
35%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Capital Expenditures
-$210k
|
CAGR 3-Years
35%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Capital Expenditures
-$5.5m
|
CAGR 3-Years
-114%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-30%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Capital Expenditures
-₪7.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
No Stocks Found
Tikun Olam Cannbit Pharmaceuticals Ltd
Glance View
Tikun Olam-Cannbit Pharmaceuticals Ltd. engages in the cultivation and marketing of medical cannabis. The firm engages in growing and cultivating medical cannabis products.
TKUN
Intrinsic Value
3 181.18
ILS
Undervaluation 32%
T
See Also
What is Tikun Olam Cannbit Pharmaceuticals Ltd's Capital Expenditures?
Capital Expenditures
71k
ILS
71k
ILS
Based on the financial report for Jun 30, 2025, Tikun Olam Cannbit Pharmaceuticals Ltd's Capital Expenditures amounts to 71k ILS.
